Posttransplant cyclophosphamide–containing prophylaxis correlated with lower aGVHD risk than tacrolimus/methotrexate, and ATG/alemtuzumab use contributed to risk estimation. Clinical utility includes ...
What to expect from a marketing analyst in 2026, how the market has changed, and what does AI have to do with it?
Spring Health reports absenteeism can cost organizations over $1 million annually; tackling its root causes is vital for maintaining productivity.
BACKGROUND: Forecasts for the future prevalence of cardiovascular disease and stroke are crucial to guide efforts to improve health outcomes across the life course for women. METHODS: Using historical ...
I watched a $47 million Enterprise Resource Planning (ERP) implementation fail spectacularly last year. The technology was flawless. The security ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention. PHILADELPHIA, PA / ACCESS ...
LabGenius Therapeutics will present preclinical data for LGTX-101, its AI-designed Nectin-4 x CD3 T-cell engager, at AACR 2026 in San Diego.
By year-end, we are happy to report that we had 107 partners who are running 407 active programs. As our partner pipeline advances, certain later-stage programs are now coming into focus with the ...